BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37550801)

  • 1. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
    Scott E; Archer Goode E; Garnham R; Hodgson K; Orozco-Moreno M; Turner H; Livermore K; Putri Nangkana K; Frame FM; Bermudez A; Jose Garcia Marques F; McClurg UL; Wilson L; Thomas H; Buskin A; Hepburn A; Duxfield A; Bastian K; Pye H; Arredondo HM; Hysenaj G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Singh S; Johnston EW; Punwani S; Knight B; McCullagh P; McGrath J; Crundwell M; Harries L; Heer R; Maitland NJ; Whitaker H; Pitteri S; Troyer DA; Wang N; Elliott DJ; Drake RR; Munkley J
    J Pathol; 2023 Sep; 261(1):71-84. PubMed ID: 37550801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Majority of alpha2,6-sialylated glycans in the adult mouse brain exist in O-glycans: SALSA-MS analysis for knockout mice of alpha2,6-sialyltransferase genes.
    Ohmi Y; Nishikaze T; Kitaura Y; Ito T; Yamamoto S; Sugiyama F; Matsuyama M; Takahashi Y; Takeda A; Kawahara T; Okajima T; Furukawa K; Furukawa K
    Glycobiology; 2021 Jun; 31(5):557-570. PubMed ID: 33242079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface.
    Zou X; Lu J; Deng Y; Liu Q; Yan X; Cui Y; Xiao X; Fang M; Yang F; Sawaki H; Sato T; Tan B; Lu X; Feng B; Kuno A; Narimatsu H; Gao C; Zhang Y
    Oncogene; 2023 Feb; 42(7):516-529. PubMed ID: 36528750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone.
    Hodgson K; Orozco-Moreno M; Goode EA; Fisher M; Garnham R; Beatson R; Turner H; Livermore K; Zhou Y; Wilson L; Visser EA; Pijnenborg JF; Eerden N; Moons SJ; Rossing E; Hysenaj G; Krishna R; Peng Z; Nangkana KP; Schmidt EN; Duxfield A; Dennis EP; Heer R; Lawson MA; Macauley M; Elliott DJ; Büll C; Scott E; Boltje TJ; Drake RR; Wang N; Munkley J
    EBioMedicine; 2024 May; 104():105163. PubMed ID: 38772281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ST6GAL1: A key player in cancer.
    Garnham R; Scott E; Livermore KE; Munkley J
    Oncol Lett; 2019 Aug; 18(2):983-989. PubMed ID: 31423157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Galactoside α2,6-sialyltranferase 1 promotes transforming growth factor-β-mediated epithelial-mesenchymal transition.
    Lu J; Isaji T; Im S; Fukuda T; Hashii N; Takakura D; Kawasaki N; Gu J
    J Biol Chem; 2014 Dec; 289(50):34627-41. PubMed ID: 25344606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ST6Gal1 in plasma is dispensable for IgG sialylation.
    Oswald DM; Lehoux SD; Zhou JY; Glendenning LM; Cummings RD; Cobb BA
    Glycobiology; 2022 Aug; 32(9):803-813. PubMed ID: 35746897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of core fucosylation in both ST6GAL1 and its substrate enhances glycoprotein sialylation in mice.
    Huang G; Li Z; Li Y; Liu G; Sun S; Gu J; Kameyama A; Li W; Dong W
    Biochem J; 2020 Mar; 477(6):1179-1201. PubMed ID: 32141499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Inhibitory Role of α2,6-Sialylation in Adipogenesis.
    Kaburagi T; Kizuka Y; Kitazume S; Taniguchi N
    J Biol Chem; 2017 Feb; 292(6):2278-2286. PubMed ID: 28031460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ST6GAL1 and α2-6 Sialylation Regulates IL-6 Expression and Secretion in Chronic Obstructive Pulmonary Disease.
    Krick S; Helton ES; Easter M; Bollenbecker S; Denson R; Zaharias R; Cochran P; Vang S; Harris E; Wells JM; Barnes JW
    Front Immunol; 2021; 12():693149. PubMed ID: 34290711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of α2,6-sialyltransferases for sialylation of therapeutic proteins.
    Janesch B; Saxena H; Sim L; Wakarchuk WW
    Glycobiology; 2019 Sep; 29(10):735-747. PubMed ID: 31281932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-localized ST6Gal1 does not impact IgG sialylation.
    Glendenning LM; Zhou JY; Kukan EN; Gao C; Cummings RD; Joshi S; Whiteheart SW; Cobb BA
    Glycobiology; 2023 Dec; 33(11):943-953. PubMed ID: 37379323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α2,6 Sialylation mediated by ST6GAL1 promotes glioblastoma growth.
    Gc S; Tuy K; Rickenbacker L; Jones R; Chakraborty A; Miller CR; Beierle EA; Hanumanthu VS; Tran AN; Mobley JA; Bellis SL; Hjelmeland AB
    JCI Insight; 2022 Nov; 7(21):. PubMed ID: 36345944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-1-mediated cell adhesion, invasion and cell death in human anaplastic large cell lymphoma: regulatory roles of cell surface glycans.
    Suzuki O; Abe M
    Int J Oncol; 2014 May; 44(5):1433-42. PubMed ID: 24589677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent Golgi trafficking limits B cell-mediated IgG sialylation.
    Glendenning LM; Zhou JY; Reynero KM; Cobb BA
    J Leukoc Biol; 2022 Dec; 112(6):1555-1566. PubMed ID: 35726710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-linked α2,6-sialylation of integrin β1 by the sialyltransferase ST6Gal1 promotes cell proliferation and stemness in gestational trophoblastic disease.
    Liu J; Dong X; Xie R; Tang Y; Thomas AM; Li S; Liu S; Yu M; Qin H
    Placenta; 2024 Apr; 149():18-28. PubMed ID: 38490094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal Stromal Cells Regulate Sialylations of N-Glycans, Affecting Cell Migration and Survival.
    Templeton K; Ramos M; Rose J; Le B; Zhou Q; Cressman A; Ferreyra S; Lebrilla CB; Fierro FA
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression.
    Lin N; Mascarenhas J; Sealover NR; George HJ; Brooks J; Kayser KJ; Gau B; Yasa I; Azadi P; Archer-Hartmann S
    Biotechnol Prog; 2015; 31(2):334-46. PubMed ID: 25641927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic basis for N-glycan sialylation: structure of rat α2,6-sialyltransferase (ST6GAL1) reveals conserved and unique features for glycan sialylation.
    Meng L; Forouhar F; Thieker D; Gao Z; Ramiah A; Moniz H; Xiang Y; Seetharaman J; Milaninia S; Su M; Bridger R; Veillon L; Azadi P; Kornhaber G; Wells L; Montelione GT; Woods RJ; Tong L; Moremen KW
    J Biol Chem; 2013 Nov; 288(48):34680-98. PubMed ID: 24155237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ST6GAL1 sialyltransferase promotes acinar to ductal metaplasia and pancreatic cancer progression.
    Bhalerao N; Chakraborty A; Marciel MP; Hwang J; Britain CM; Silva AD; Eltoum IE; Jones RB; Alexander KL; Smythies LE; Smith PD; Crossman DK; Crowley MR; Shin B; Harrington LE; Yan Z; Bethea MM; Hunter CS; Klug CA; Buchsbaum DJ; Bellis SL
    JCI Insight; 2023 Oct; 8(19):. PubMed ID: 37643018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.